Wednesday, 19 February 2020

Pfizer Vaccines launches global centers of excellence network

24 January 2020 | News

University of Louisville Named First Center of Excellence

image credit- istock.com

image credit- istock.com

Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden of specific vaccine-preventable diseases and potentially evaluate vaccine effectiveness affecting adults.

Pfizer Vaccines has designated the University of Louisville in the US as its first Center of Excellence with a second global center anticipated in the first half of 2020.

As Pfizer’s first Center of Excellence site, the University of Louisville will initially conduct two separate, large population-based epidemiological studies in adults: a one-year study of the incidence of infectious diarrhea with funding provided by Pfizer up to $6.5 million and a one-year study of the incidence of pneumonia with funding provided by Pfizer up to $4.5 million.

Pfizer Vaccines is currently planning to establish a few additional Centers of Excellence for epidemiological research strategically located around the world in the coming years.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account